疫苗研究
ENGLISH ABSTRACT
用于Sabin株脊髓灰质炎灭活疫苗生产的无酚红M199培养基贮存效期验证
刘英微
刘哲宇
田东阳
李建新
张萌
李娜
作者及单位信息
·
DOI: 10.3760/cma.j.cn311962-20240223-00009
Validity period verification of phenol red-free M199 medium in Sabin strain inactivated poliovirus vaccine
Liu Yingwei
Liu Zheyu
Tian Dongyang
Li Jianxin
Zhang Meng
Li Na
Authors Info & Affiliations
Liu Yingwei
Project Group One,Beijing Institute of Biological Products Co.,Ltd.,Beijing 100176,China
Liu Zheyu
Quality Control Department,Beijing Institute of Biological Products Co.,Ltd.,Beijing 100176,China
Tian Dongyang
Project Group One,Beijing Institute of Biological Products Co.,Ltd.,Beijing 100176,China
Li Jianxin
No.5 Department of Vaccine,Beijing Institute of Biological Products Co.,Ltd.,Beijing 100176,China
Zhang Meng
No.5 Department of Vaccine,Beijing Institute of Biological Products Co.,Ltd.,Beijing 100176,China
Li Na
Quality Assurance Department,Beijing Institute of Biological Products Co.,Ltd.,Beijing 100176,China
·
DOI: 10.3760/cma.j.cn311962-20240223-00009
24
9
0
0
0
0
PDF下载
APP内阅读
摘要

目的验证无酚红M199培养基的贮存效期,同时探索无酚红M199效期对无酚红Sabin株脊髓灰质炎灭活疫苗(inactivated Sabin strain poliovirus vaccine,sIPV)关键质量属性的影响。

方法对贮存0、6、12、18、24、30、36及42个月的3批次无酚红M199干粉培养基进行外观、澄清度、pH、干燥失重、细菌内毒素、微生物限度等物理化学性质及微生物性质长期监测;检测用贮存36个月并检定合格的无酚红M199制备的sIPV成品关键质量属性;将近效期和远效期无酚红M199制备的各3批sIPV分别贮存于37 ℃和25 ℃进行稳定性监测,检测D抗原含量,评价其稳定性;用2组sIPV免疫大鼠,检测大鼠血清抗体效价,评价其免疫原性。

结果无酚红M199干粉培养基于2~8 ℃贮存42个月后的外观、澄清度、pH、干燥失重、细菌内毒素、微生物限度等均合格;用贮存36个月无酚红M199所制备sIPV成品的pH、D抗原、蛋白含量、Vero细胞DNA残留量、牛血清白蛋白残留量、Vero细胞蛋白残留量、游离甲醛含量等各项检定结果均符合中国药典2020年版三部和企业标准要求;用贮存36个月无酚红M199制备的sIPV效价合格、稳定性良好且与远效期无酚红sIPV免疫原性趋势一致,效力( t =-0.15~2.17, P>0.05)和诱导中和抗体水平( t =-1.46~2.02, P>0.05)差异均无统计学意义。

结论用贮存至36个月的无酚红M199制备的sIPV成品稳定性较好,近效期和远效期无酚红M199制备的sIPV产品质量属性、免疫原性及稳定性趋势一致,且对产品质量无影响,无酚红培养基的效期初步可定为36个月。

脊髓灰质炎病毒疫苗,灭活;无酚红培养基;制剂;贮存效期
ABSTRACT

ObjectiveTo validate the storage potency of phenol red-free M199 medium and explore the effect of phenol red-free M199 potency on the key quality attributes of phenol red-free Sabin strain inactivated poliovirus vaccine (sIPV).

MethodsThe appearance, clarity, pH, weight loss on drying, bacterial endotoxin, microbial limit and other physical and chemical properties of 3 batches of phenol red-free M199 powder culture medium stored for 0, 6, 12, 18, 24, 30, 36 and 42 months were monitored. Key quality attributes of final sIPV products prepared with phenol red-free M199 calibration qualified after 36 months of storage were detected. The sIPVs prepared with near- and far-period phenol red-free M199 were stored at 37 ℃ and 25 ℃, respectively, for stability monitoring and evaluation by detecting the D antigen content.The 2 groups of sIPVs were used to immunize rats, and the immunogenicity was evaluated by detecting the antibody potency of rat serum.

ResultsThe appearance, clarity, pH, loss on drying, bacterial endotoxin, microbial limit of phenol red-free M199 dry powder culture medium stored at 2~8 ℃ for 42 months were all qualified. The pH, D antigen content, protein content, Vero cell DNA residue, bovine serum albumin residue, Vero cell protein residue, free formaldehyde content and other test results of sIPV produced using phenol red-free M199 stored for 36 months were in line with the requirements of the Chinese pharmacopoeia 2020 edition volume Ⅲ and the enterprise standards. The sIPV prepared with phenol red-free M199 stored up to 36 months was potent with good stability, and the trend of immunogenicity was consistent with that of the sIPV prepared with far-period phenol red-free M199, with no statistically significant differences in potency( t =-0.15-2.17, P>0.05)or neutralizing antibody level( t =-1.46-2.02, P>0.05).

ConclusionsThe sIPV final product prepared with phenol red-free M199 stored up to 36 months has good stability. The product quality attributes, immunogenicity and stability of sIPV products prepared with near- and far-period M199 show the same trend, and near-period M199 has no effect on the product quality. Phenol red-free media can be valid for 36 months.

Poliovirus vaccine, inactivated;Phenol red free medium;Preparations;Storage life
Li Na, Email: mocdef.mabrahponis1anil
引用本文

刘英微,刘哲宇,田东阳,等. 用于Sabin株脊髓灰质炎灭活疫苗生产的无酚红M199培养基贮存效期验证[J]. 国际生物制品学杂志,2025,48(01):20-25.

DOI:10.3760/cma.j.cn311962-20240223-00009

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
Sabin株脊髓灰质炎(脊灰)灭活疫苗(Sabin strain inactivated poliomyelitis vaccine,sIPV)是目前预防脊灰最安全有效的疫苗,多年临床研究数据表明其具备良好的安全性和免疫原性 1 , 2 , 3 , 4 , 5 , 6。M199培养基是sIPV生产过程中的关键物料,用于细胞传代培养、半成品配制等工艺过程,在制剂阶段起重要的稳定剂和保护剂作用,其质量属性及效期等对疫苗产品质量有重要的影响。M199培养基一般添加酚红作为酸碱指示剂,而酚红为疫苗非目标成分。近年来,对疫苗终产品中杂质和防腐剂的规定越来越严格,用无酚红培养基代替有酚红培养基成为业界共识。然而,用无酚红M199培养基生产sIPV时,其效期及无酚红sIPV成品的质量属性均需验证。本研究通过验证3批无酚红M199的贮存效期,比较用远效期及近效期无酚红M199制备的sIPV的质量属性、稳定性及免疫原性,综合评价无酚红M199的质量属性,明确无酚红M199培养基效期对产品质量的影响,为研究无酚红培养基的贮存效期以及无酚红sIPV成品质量属性提供初步依据。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Yin QZ Zheng Y Ying ZF et al. Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18-24 months:a phase Ⅵ clinical trial[J]. Vaccine 2024428):1973-1979. DOI: 10.1016/j.vaccine.2024.02.042 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
刘小琴陈海平张振国. Sabin株脊髓灰质炎灭活疫苗(Vero细胞)上市后的安全性评价[J]. 中国生物制品学杂志 20193212):1386-1389. DOI: 10.13200/j.cnki.cjb.002918 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Jiang RJ Liu XQ Sun XD et al. Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase Ⅳ clinical trial for the vaccination of a large population[J]. Vaccine 2021399):1463-1471. DOI: 10.1016/j.vaccine.2021.01.027 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Yan SH Chen HP Zhang ZG et al. Immunogenicity and safety of different sequential schedules of Sabin strain based inactivated poliovirus vaccination:a randomized,controlled,open-label,phase Ⅳ clinical trial in China[J]. Vaccine 20203840):6274-6279. DOI: 10.1016/j.vaccine.2020.07.042 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Deng Y Cai W Li JY et al. Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing[J]. Vaccine 2019371):130-136. DOI: 10.1016/j.vaccine.2018.11.020 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Modlin JF Chumakov K . Sabin strain inactivated polio vaccine for the polio endgame [J]. J Infect Dis 20202214):504-505. DOI: 10.1093/infdis/jiz077 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
国家药典委员会. 中华人民共和国药典2020年版三部[M]. 北京中国医药科技出版社 20205201.
[8]
曾琴徐凤姣熊昀. 酚红对无血清悬浮培养条件下肿瘤干细胞微球形成的影响[J]. 华西药学杂志 2017324):388-390. DOI: 10.13375/j.cnki.wcjps.2017.04.014 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Morgan A Babu D Reiz B et al. Caution for the routine use of phenol red—it is more than just a pH indicator[J]. Chem Biol Interact 2019309):297-301. DOI: 10.1016/j.cbi.2019.108739 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Ma Y Ying ZF Li JY et al. Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats[J]. Biologicals 2022751):3-11. DOI: 10.1016/j.biologicals.2022.01.005 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
赵玉秀李爱灵梁宏阳. Sabin株脊髓灰质炎灭活疫苗在动物体内的免疫原性及安全性评价[J]. 中国生物制品学杂志 2015287):665-669. DOI: 10.13200/j.cnki.cjb.000949 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
邱丰李映波丁士磊. Sabin 株脊髓灰质炎灭活疫苗对大鼠的免疫效果[J]. 中国生物制品学杂志 20072011):829-830,840. DOI: 10.13200/j.cjb.2007.11.42.qiuf.004 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
李娜,Email: mocdef.mabrahponis1anil
B

刘英微:实验设计、研究实施、数据采集、数据分析、统计分析、论文撰写;刘哲宇、李建新:研究实施、数据采集、数据分析、统计分析、技术支持、研究指导;田东阳:研究实施、数据采集、数据分析、技术支持、研究指导;张萌:研究实施、数据采集、数据分析;李娜:实验设计、研究实施、统计分析、论文撰写、论文修改、支持性贡献

C
所有作者均声明不存在利益冲突
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号